Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI
Phase 4
- Conditions
- Left Ventricular Ejection FractionSurvival Myocardial Area After Acute Myocardial Death
- Interventions
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2019-05-22
- Lead Sponsor
- Dalian Zhen-Ao Bio-Tech Co., Ltd.
- Target Recruit Count
- 160
- Registration Number
- NCT03958422
Phase IIaTrials of GanMaoKangNing Granules
Phase 2
- Conditions
- Epidemic Influenza
- Interventions
- Drug: GanMaoKangNing GranulesDrug: Analogous GanMaoKangNing Granules
- First Posted Date
- 2016-12-12
- Last Posted Date
- 2016-12-12
- Lead Sponsor
- Dalian Zhen-Ao Bio-Tech Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT02989012
- Locations
- 🇨🇳
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Beijing Shi, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath